These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23480248)

  • 21. Medically assisted treatment for opiate addiction--suboxone method as prevention of social exclusion of youth--Tuzla model.
    Hasanović M; Pajević I; Kuldija A; Delić A
    Psychiatr Danub; 2012 Oct; 24 Suppl 3():S398-404. PubMed ID: 23114824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose.
    Clark NC; Lintzeris N; Muhleisen PJ
    Med J Aust; 2002 Feb; 176(4):166-7. PubMed ID: 11913917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a naloxone distribution and administration program in New York City.
    Piper TM; Stancliff S; Rudenstine S; Sherman S; Nandi V; Clear A; Galea S
    Subst Use Misuse; 2008; 43(7):858-70. PubMed ID: 18570021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buprenorphine and nor-buprenorphine levels in head hair samples from former heroin users under Suboxone® treatment.
    Belivanis S; Tzatzarakis MN; Vakonaki E; Kovatsi L; Mantsi M; Alegakis A; Kavvalakis MP; Vynias D; Tsatsakis AM
    Drug Test Anal; 2014 Jun; 6 Suppl 1():93-100. PubMed ID: 24817054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buprenorphine in the treatment of opiate dependence: its pharmacology and social context of use in the U.S.
    Wesson DR
    J Psychoactive Drugs; 2004 May; Suppl 2():119-28. PubMed ID: 15279124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buprenorphine therapy: an increasing challenge in oral and maxillofacial surgery.
    Wasson M; Beirne OR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):142-6. PubMed ID: 23849373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
    Curcio F; Franco T; Topa M; Baldassarre C;
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.
    Alho H; Sinclair D; Vuori E; Holopainen A
    Drug Alcohol Depend; 2007 Apr; 88(1):75-8. PubMed ID: 17055191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buprenorphine and naloxone interactions in opiate-dependent volunteers.
    Mendelson J; Jones RT; Fernandez I; Welm S; Melby AK; Baggott MJ
    Clin Pharmacol Ther; 1996 Jul; 60(1):105-14. PubMed ID: 8689806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diverse clinical uses of opioid receptor drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 May; 48(5):11-4. PubMed ID: 20415289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic epidemiology of opiate misuse substitution treatment in Belgium.
    Ledoux Y
    J Pharm Belg; 2012 Sep; (3):30-9. PubMed ID: 23697094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
    Bell J; Shanahan M; Mutch C; Rea F; Ryan A; Batey R; Dunlop A; Winstock A
    Addiction; 2007 Dec; 102(12):1899-907. PubMed ID: 17784896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine/naloxone combination (Suboxone).
    Simojoki K; Vorma H; Alho H
    Subst Abuse Treat Prev Policy; 2008 Jun; 3():16. PubMed ID: 18559110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid dependence.
    Praveen KT; Law F; O'Shea J; Melichar J
    Am Fam Physician; 2012 Sep; 86(6):565-6. PubMed ID: 23062049
    [No Abstract]   [Full Text] [Related]  

  • 40. A clinical trial of buprenorphine: I. Comparison with methadone in the detoxification of heroin addicts. II. Examination of its opioid blocking properties.
    Bickel WK; Johnson RE; Stitzer ML; Bigelow GE; Liebson IA; Jasinski DR
    NIDA Res Monogr; 1987; 76():182-8. PubMed ID: 2449618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.